Phupinder Gill retired as CEO of CME Group in 2016, after four years running the firm’s day-to-day operations and implementing strategic initiatives to expand CME’s core business into new areas of listed, overthe-counter and emerging markets. He first joined the company in 1988.
From 2004 to 2012, Gill served as CME Group’s president and COO since 2004, where he oversaw the divisions responsible for products and services, technology, global operations, clearing, enterprise solutions, and research and product development.
From 2000 to 2003, Gill was managing director and president of CME Clearing. In 2003, he led the implementation of the company’s historic clearing agreement with the Chicago Board of Trade under which CME provided clearing and backoffice processing for all CBOT products. This agreement helped pave the way for the 2007 merger of the two institutions.
Previously, Gill was responsible for implementing the CLEARING 21 system and CME’s cross-margining arrangement with the Options Clearing Corporation.
Gill served on CME Group’s Board of Directors, as well as the board of the World Federation of Exchanges and WFE’s Regulatory Policy Committee. He continues to serve on the board of directors of First Midwest Bancorp Inc. and The Alexander Maxwell Grant Foundation.